Immune Regulation by Gadd45b and Gadd45g
Immune Regulation by Gadd45b and Gadd45g
批准号:
7545810
负责人:
Binfeng Lu
金额:
$30.16万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-01-01 至 2010-12-31
关键词:
AffectApoptosisApoptoticAutoimmune DiseasesAutoimmunityB-LymphocytesCD4 Positive T LymphocytesCellsClinicalComplexDataDevelopmentDiseaseDisease MarkerEffector CellEncephalomyelitisExperimental Autoimmune EncephalomyelitisFamilyFamily memberFlow CytometryG2/M TransitionGADD45GADD45A geneGADD45BGADD45B/GADD45GGADD45GGene FamilyGenesGrowthHistocytochemistryHomeostasisImmuneInfectionInterleukin-10Interleukin-12Interleukin-18KineticsLeadListeria monocytogenesLupusLymphoid TissueMAPK14 geneMediatingMitogen-Activated Protein KinasesModelingMolecularMultiple SclerosisMusPeripheralPhenotypePlayProtein FamilyRegulationRoleSignal TransductionSpleenSplenomegalyT-Cell ProliferationT-LymphocyteTestingTh1 CellsTransgenic OrganismsWild Type Mouseinsightmembermitogen-activated protein kinase p38mouse modelnovel strategiespreventresponse
中文摘要
我们的长期目标是了解控制自身免疫性疾病的分子机制。我们的
目前的焦点是一个名为GADD45(生长停滞和DNA损伤诱导)的基因家族,它
由三个成员组成,Gadd45a、Gadd45b和Gadd45g。Gadd45a被证明参与了
调节T细胞的动态平衡和缺乏Gadd45a被认为是导致狼疮的原因。另外两个人的角色
家族成员Gadd45b和Gadd45g在自身免疫性疾病中的作用尚不清楚。在Th1细胞中,Gadd45b和
Gadd45g,而不是Gadd45a,是由TCP信号或IL-12和IL-18诱导的。我们发现,缺乏
Gadd45b和Gadd45g导致抗单核细胞增多性李斯特菌的Th1细胞数量急剧减少。
预计Th1细胞数量较少,但我们惊讶地看到Gadd45b缺失导致
加重实验性变态反应性脑脊髓炎(EAE),临床症状更严重,延长
炎症的中枢神经系统中的病程和自身反应性Th1细胞的增加。Gadd45b的缺失也导致了
老年小鼠的脾增大。Gadd45B/Gadd45G双缺乏进一步加剧了这种表型和
导致与Gadd45b单缺失相比,老年小鼠的脾大大增大。的扩大。
脾是由于活化表型的CD4T细胞和B细胞的聚集所致。我们的数据
提示Gadd45b和Gadd45g在调节活化的CD4T细胞中起协同作用。此外,
我们发现Gadd45b和Gadd45g抑制了细胞的增殖,并且是激活的细胞凋亡所必需的
CD4T细胞。在这个提议中,我们检验了GADD45蛋白家族成员Gadd45b的假设
和Gadd45G是自身免疫的重要负性调节因子。具体来说,我们计划:1.提供明确的
证明Gadd45b和Gadd45g协调调节自身免疫性疾病,2.确定Gadd45b和Gadd45g是否
Gadd45G在控制EAE中T细胞增殖和凋亡中起关键作用;3.分子研究
Gadd45b和Gadd45G调节Th1细胞增殖和凋亡的机制监管
GADD45家族分子对外周效应CD4T细胞增殖和凋亡的影响
新的自身免疫调控机制。
相关性:这项研究将导致开发针对这些分子的新策略来治疗或
预防自身免疫性疾病。这项研究还将揭示自身免疫性疾病的新疾病标志物。
英文摘要
Our long term objective is to understand the molecular mechanisms that control autoimmune diseases. Our
immediate focus is on a gene family called Gadd45 (growth-arrest and DNA damage-inducible) which
consists of three members,Gadd45a, Gadd45b, and Gadd45g. Gadd45a was shown to be involved in
regulating homeostasis of T cells and lack of Gadd45a was known to cause lupus. The role of the other two
family members, Gadd45b and Gadd45g, in autoimmune diseases is not clear. In Th1 cells, Gadd45b and
Gadd45g, but not Gadd45a, are induced by TCP signaling or IL-12 and IL-18. We have found that the lack of
Gadd45b and Gadd45g results in a drastically reduced number of Th1 cells against Listeria monocytogenes.
Expecting low numbers of Th1 cells, we were surprised to see that Gadd45b deletion resulted in
exacerbated experimental allergic encephalomyelitis (EAE) with more severe clinical signs, a prolonged
disease course and increased autoreactive Th1 cells in the inflamed CNS. Gadd45b deletion also resulted in
enlarged spleens in older mice. Gadd45b/Gadd45g double-deficiency further aggravated this phenotype and
resulted in greatly enlarged spleens in older mice compared to Gadd45b single deletion. The enlargement of
spleens was due to the accumulation of CD4+ T cells with an activated phenotype and B cells. Our data
suggest that Gadd45b and Gadd45g play a synergistic role in regulating activated CD4+ T cells. In addition,
we found that Gadd45b and Gadd45g inhibited proliferation and were required for apoptosis of activated
CD4+ T cells. In this proposal we are testing the hypothesis that Gadd45 protein family members Gadd45b
and Gadd45g are important negative regulators of autoimmunity. Specifically we plan to: 1. provide definitive
proof that Gadd45b and Gadd45g coordinately regulate autoimmune diseases, 2. determine if Gadd45b and
Gadd45g are critical for the control of T cell proliferation and apoptosis in EAE, and 3. study molecular
mechanisms that regulate the proliferation and apoptosis of Th1 cells by Gadd45b and Gadd45g. Regulation
of proliferation and apoptosis in peripheral effector CD4+ T cells by Gadd45 family of molecules provides a
new regulatory mechanism for autoimmunity.
Relevance: This study will lead to the development of novel strategies targeting these molecules to treat or
prevent autoimmune diseases. This study will also reveal new disease markers for autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10703824
-
项目类别:
-
资助金额:$24.42万
-
财政年份:2022
-
负责人:Binfeng Lu
-
依托单位:
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10625415
-
项目类别:
-
资助金额:$39.31万
-
财政年份:2022
-
负责人:Binfeng Lu
-
依托单位:
Study of the IL-33-driven immune cell organization underpinning responses to immune checkpoint blockade cancer therapy
-
批准号:10431979
-
项目类别:
-
资助金额:$13.3万
-
财政年份:2021
-
负责人:Binfeng Lu
-
依托单位:
Dissecting the role of the ATF4 stress response in T cell-mediated inflammation
-
批准号:9240576
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2016
-
负责人:Binfeng Lu
-
依托单位:
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
-
批准号:8602513
-
项目类别:
-
资助金额:$19.4万
-
财政年份:2013
-
负责人:Binfeng Lu
-
依托单位:
Cellular and molecular mechanisms underlying IL-33-mediated anti-tumor immunity
-
批准号:8443458
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2013
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7330322
-
项目类别:
-
资助金额:$30.16万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7031286
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7162073
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Immune Regulation by Gadd45b and Gadd45g
-
批准号:7746479
-
项目类别:
-
资助金额:$29.86万
-
财政年份:2006
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:7216788
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:7055357
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6766894
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6879128
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
Regulation of the MAP kinase pathway in the CD4+ T cells
-
批准号:6614073
-
项目类别:
-
资助金额:$11.99万
-
财政年份:2003
-
负责人:Binfeng Lu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: